Polo-Like Kinase 2 Promotes Chemoresistance and Predicts Limited Survival Benefit From Adjuvant Chemotherapy in Colorectal Cancer
International Journal of Oncology - Greece
doi 10.3892/ijo.2018.4328
Full Text
Open PDFAbstract
Available in full text
Date
March 20, 2018
Authors
Publisher
Spandidos Publications